UREX BIOTECH INC. – Trademark Portfolio

Entity Type: 03

UREX BIOTECH INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include GR-1 and RC-14. The owner is based in LONDON, ONTARIO.

THE UNIVERSITY OF WESTERN ONTARIO, STEVENSON-LAWSON BUILDING

LONDON, ONTARIO N6A 5B8 , CA

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RC-14
RC-14
Registered 2004
GR-1
GR-1
Registered 2004
NURTUROL
NURTUROL
Abandoned 2001
RC-14
RC-14
Abandoned 1999
GR-1
GR-1
Abandoned 1998

Trademark Classifications

UREX BIOTECH INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does UREX BIOTECH INC. have?

UREX BIOTECH INC. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned.

What trademark classes does UREX BIOTECH INC. file in?

UREX BIOTECH INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are UREX BIOTECH INC.'s most well-known trademarks?

UREX BIOTECH INC.'s registered trademark portfolio includes well-known marks such as GR-1 and RC-14. These are among 2 currently registered trademarks in the portfolio.

What is UREX BIOTECH INC.'s trademark registration success rate?

UREX BIOTECH INC. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.